Stay updated with breaking news from Ancer Immunotherapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A class of cancer immunotherapy called checkpoint inhibitors has revolutionized cancer treatment. It's a new way to attack the disease by unleashing the immune system.
In this interview, News-Medical talks to Dr. Brendan Horton about his latest research which has shed new light on cancer and T cells.
A common medication used to treat reflux, heart burn and ulcers could lessen the effectiveness of lung cancer immunotherapy drugs, according to new Flinders University research.
Under the right circumstances, the body's T cells can detect and destroy cancer cells. However, in most cancer patients, T cells become disarmed once they enter the environment surrounding a tumor.
Astronomy Meets Pathology for Immunotherapy Research The Johns Hopkins AstroPath™ team used Akoya’s Phenoptics technology to image tumor tissue samples and analyzed spatial interactions between tumor and immune cells using astronomy algorithms. Lung Cancer Whole Tissue Phenoptics Image Akoya’s Phenoptics™ platform captures high resolution images of whole tumor sections from patients, enabling researchers to study the spatial biology of the sample – i.e., how tumor and immune cells interact withi